Super Bowl ad for Hims & Hers' weight loss drug sparks backlash
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, which both contain the active ingredient semaglutide and are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes and obesity, respectively.
The company expanded into weight loss in late 2023 with oral medication kits and added compounded GLP-1 ...
Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with ... demand for its compounded drugs. Using the home kits will allow Hims to ...
The "Hims and Hers" commercial railed against ... Narula explains the findings of a new study on GLP-1 drugs commonly used for weight loss. Dr. Alexandra Sowa, an obesity medicine specialist ...
During Sunday’s Super Bowl, Hims & Hers Health ... to life-saving weight loss treatments.” The ad is just the latest flashpoint in a battle over compounded GLP-1 drugs.
Hims & Hers is under scrutiny for promoting compounded weight-loss ... medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1, ...
Hims has accelerated its impressive growth from 46% two quarters ago to 77% now. Forward guidance is at an even stronger 90%, which is largely due to growth in GLP-1’s for their weight loss ...
That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super Bowl ad, leveling the accusation against brand-name weight loss ... of these medications, known as compounded ...
Cleverly targeting the high-demand, weight-loss drug segment, the company dramatically pushed its obesity offerings in a cutting-edge, one-minute spot. It's important to note here that Hims & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback